Skip to content
★ Sign in to follow
JJ

Jingrong Jean Cui

CEO
BlossomHill Therapeutics, Inc.Turning Point Therapeutics, Inc.
Total declarations
186
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (179 ops.)
€36.7M

Latest filing published 10 Aug 2026 for BlossomHill Therapeutics, Inc..

Filing timeline

BuySale
Jingrong Jean Cui

Insider track record

Disclosed buys
0
Disclosed sells
179
Signal history

Jingrong Jean Cui: trading record in brief

Filings by Jingrong Jean Cui span 2 companies, the busiest being Turning Point Therapeutics, Inc. and BlossomHill Therapeutics, Inc. Over a trading history stretching from 27 June 2019 to 10 August 2026, the count stands at 186 filings.

Sales make up the whole of the open-market record (179 sales, €36.7M). Besides market trades, the filings include 4 option exercises.

The newest entry dates from 10 August 2026: a transaction, in BlossomHill Therapeutics, Inc. Typically, a trade is published a median of 1 day after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Jingrong Jean Cui

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations186 total

25 of 186 declarations